Whether the lack of BubR1-PP2A mediated end-on conversion event(s) is an important reason for higher sensitivity to loss of BubR1 in Brain Tumour Initiating Cells compared to normal cells52 would be interesting to explore in the future. The gene discussed is PTPA; the disease is brain neoplasm.